| Indications broaden for colorectal liver mets resection
About 15 percent of patients with colorectal liver metastases are candidates for potentially curative surgical resection, but many don't receive it. Experienced centers with multidisciplinary teams can now successfully treat some patients whose tumors were once considered unresectable.
FDA and CMS approve Cologuard for CRC screening
Recently approved by the FDA and simultaneously covered by Medicare, Cologuard is a noninvasive stool DNA screening test for colorectal cancer with demonstrated 92 percent sensitivity in detecting cancer stages I-IV and 94 percent sensitivity for detecting early-stage CRC.
Chronic cough clinic addresses non-acid reflux, neuronal hypersensitivity
A unique chronic cough clinic at Mayo's campus in Jacksonville, Florida, provides comprehensive evaluation and treatment for patients with refractory cough symptoms, including those who fail to respond to acid suppression therapy.
Endoscopic teams specialize in difficult GI lesions
Endoscopic management of difficult gastrointestinal lesions and post-procedural complications requires special expertise. All three Mayo Clinic campuses have specialty endoscopic teams that provide interventions and consultations for challenging cases.
| 
